Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The Classification & Diagnosis of Granulomatosis with Polyangiitis

Harry E. Subramanian, Ravi Sutaria, MD, & Fotios Koumpouras, MD  |  Issue: August 2018  |  August 16, 2018

The diagnosis of infective endocarditis is based on the modified Duke criteria.8 Although a definitive diagnosis can be provided only after histologic and microbial analysis of a vegetation or cardiac specimen, a clinical diagnosis of possible infective endocarditis can be made using the Duke criteria with the presence of one major and one minor criterion or of three minor criteria. The two major criteria are:

  • A positive blood culture; and
  • Evidence of endocardial involvement (an echocardiogram demonstrating a vegetation, an abscess or new valvular regurgitation).

The five minor criteria are:

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
  • A predisposing condition;
  • A fever;
  • Vascular and embolic phenomena (including arterial emboli, septic pulmonary infarcts and Janeway lesions);
  • Immunological phenomena (including glomerulonephritis, Osler nodes and rheumatoid factor); and
  • Microbiological evidence of infection that does not satisfy the major criterion.

A vegetation is defined as an oscillating intracardiac mass on a valve or supporting structures, in the path of regurgitant jets or on implanted material in the absence of an alternative anatomic explanation.

Our patient satisfied one major criterion: endocardial involvement with an echocardiogram demonstrating a mitral vegetation. In addition, she satisfied three minor criteria: a predisposing condition of dental infection and dental surgery preceding her presentation, embolic phenomenon of splinter hemorrhages in the digits and immunological phenomena of glomerulonephritis with reduced complement levels and an elevated rheumatoid factor. Therefore, our patient would meet the criteria to assign a clinical diagnosis of possible infective endocarditis.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

On the other hand, no well-established diagnostic criteria exist for the diagnosis of ANCA-associated vasculitis or GPA. Many physicians refer to the 1990 ACR classification scheme, which contains four criteria: nasal or oral inflammation, abnormal chest radiograph (with nodules, infiltrates or cavities), abnormal urinary sediment (with hematuria or red cell casts) and granulomatous inflammation on biopsy. The presence of two or more criteria yields a sensitivity and specificity of 88.2% and 92.0%, respectively for GPA.9 However, these criteria were developed prior to the routine use of ANCA and are not recommended for diagnostic purposes.

The diagnosis of GPA is typically made using clinical judgment by evaluating a patient’s symptoms together with laboratory and imaging findings while excluding other possible diagnoses, and by observation of improvement on immunosuppressive therapies.10

Our patient had many signs and symptoms that would suggest GPA, including a purpuric rash, hemoptysis and pulmonary hemorrhage resulting in respiratory failure and renal failure with hematuria. Her laboratory findings of an elevated ESR and CRP, and positive C-ANCA and PR3 antibodies, as well as lung opacities seen on chest X-ray and CT scan, were also all consistent with GPA. Her periungual skin biopsy contained thrombotic lesions more consistent with embolic phenomena from endocarditis rather than a vasculitis. However, the renal biopsy demonstrated a necrotizing glomerulonephritis with crescents and without immune complex deposits, which strongly favored GPA over infective endocarditis.

Page: 1 2 3 4 5 6 7 8 | Single Page
Share: 

Filed under:ConditionsVasculitis Tagged with:ANCAantineutrophil cytoplasmic antibodyGPAgranulomatosis with polyangiitis

Related Articles
    Figure 1. A nasal biopsy shows intimal infiltration of the small blood vessels (black arrow).

    Case Illustrates the Difficulty Diagnosing Granulomatosis with Polyangiitis

    June 21, 2018

    Granulomatosis with polyangiitis (GPA) was first described in the British Medical Journal in 1897 by Scottish otolaryngologist Peter McBride.1 GPA is a relatively rare, systemic necrotizing vasculitis that can make diagnosis challenging. The incidence has been estimated anywhere between two and 12 cases per million.2 GPA mainly affects adults between the ages of 45 and…

    Case Report: A Patient on Apremilast Develops Streptococcus Salivarius

    October 18, 2019

    Apremilast was first marketed in March 2014 for the treatment of adults with psoriatic arthritis (PsA). An immuno­modulating drug, which is a small molecule inhibitor of phosphodiesterase 4 (PDE4) specific for cyclic adenosine mono­phosphate (cAMP), apremilast is administered orally. By inhibiting PDE4, intracellular cAMP levels are increased. Although the exact mechanism of action is not…

    Rheumatology’s Architect

    March 1, 2008

    Help the REF lay foundations for our future

    The Granulomatosis of Wegener’s

    May 16, 2011

    Delving deeper into the nonvasculitis aspects of the disease

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences